Short-Term Adverse Outcomes After Deep Brain Stimulation Treatment in Patients with Parkinson Disease.

摘要: Background Despite ongoing progress in our understanding of long-term outcomes after neuromodulation procedures, acute adverse shortly deep brain stimulation (DBS) treatment have remained remarkably limited. Objective To identify risk factors associated with 30-day DBS patients Parkinson disease (PD). Methods We evaluated who underwent for PD from 2005 to 2014 through the American College Surgeons National Surgical Quality Improvement Program database. used bivariate analysis and multivariate logistic regression short-term postoperative outcomes, including complication, discharge destination, unplanned readmission. Results Overall, 650 procedures complications were identified 32 (4.9%). Of 481 had complete data, 18 (3.7%) discharged a facility 16 (3.3%) experienced an Patients obese ( P  = 0.045), preoperative anemia 0.008), longer operative durations 0.01) increased odds complications. Inpatient status  = 0.001), dependent functional 0.043) all other than home. Longer duration  = 0.013), 0.036), = 0.03) significantly As expected, likelihood readmission Conclusions This study provides individualized estimates risks based on patient demographics comorbidities. These data can be as adjunct stratification being considered treatment.